Compared to other experimental therapies, treatment with the ADHD medication lisdexamfetamine resulted in the lowest risk of hospitalization and death among people with amphetamine addiction, researchers reported on… read more.
A decades-long New Zealand national data base study suggests an association between mental disorders and subsequent dementia. The findings were published on February 16, 2022 in JAMA Psychiatry…. read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
